Nitrofurantoin Oral Suspension shortage
Nitrofurantoin Oral Suspension is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Oct 4, 2026.
Amneal Pharmaceuticals is stopping production of nitrofurantoin oral suspension (25 mg/5 mL), and this change may be permanent. Other makers, including Rising Pharma, Lupin, and Aurobindo, still list nitrofurantoin oral suspension at both 25 mg/5 mL and 50 mg/5 mL strengths.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Nitrofurantoin Oral Suspension. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Apr 10, 2026Currently in shortage1 of 1 product affected.
-
Apr 10, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Amneal Pharmaceuticals 📞 866-525-7270 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Nitrofurantoin Oral Suspension — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Nitrofurantoin Oral Suspension? options further down this page.
Why is Nitrofurantoin Oral Suspension in shortage?
Amneal Pharmaceuticals has reported to the FDA that they are permanently stopping the manufacture of their nitrofurantoin oral suspension, 25 mg/5 mL. This isn't a temporary shortage — it's a full discontinuation of that specific product from this manufacturer.
No specific reason was shared publicly for why they made this decision. It's also worth knowing that this report only reflects what Amneal submitted to the FDA — it speaks only to their product, not to what other manufacturers may or may not be doing with their own versions of this medication.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Nitrofurantoin Oral Suspension, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Nitrofurantoin Oral Suspension?
Nitrofurantoin oral suspension is currently on the FDA shortage list. This applies to the liquid form, which is often used for children or for people who have trouble swallowing pills.
The one strength on this record, 25 mg/5 mL, has no available source right now. There are no other strengths of the suspension listed to compare it against here. The reason reported is that Amneal Pharmaceuticals is discontinuing its manufacture of this product. Because this is a discontinuation rather than a temporary delay, this particular supply may not return, so it's worth planning your next step early — but this record reflects only one manufacturer, and other companies still make the same medicine.
Here is what I'd suggest, in order:
- Do not stop or change the dose on your own. Keep taking it as prescribed while you sort out supply.
- Ask your pharmacy to check other makers — the same medicine (nitrofurantoin suspension) is listed from Lupin, Aurobindo, Rising Pharma, Biocon, ANI, and NorthStar. Your pharmacy may be able to source one, though it may not be in local stock.
- If it can't be found, ask your prescriber or pharmacist about options, such as a clinician-chosen alternative.
- Manufacturer contact numbers are listed on this page; pharmacies usually make these calls.
This is general, national information and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Nitrofurantoin Oral Suspension?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Nitrofurantoin Oral Suspension is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Nitrofurantoin | NITROFURANTOIN 50 mg/5mL | Suspension · Oral | Rising Pharma Holdings, Inc. | 16571-0888-06 |
| Nitrofurantoin | NITROFURANTOIN 25 mg/5mL | Suspension · Oral | Lupin Pharmaceuticals,Inc. | 43386-0450-11 |
| Nitrofurantoin | NITROFURANTOIN MONOHYDRATE 25 mg/5mL | Suspension · Oral | Aurobindo Pharma Limited | 59651-0206-23 |
| Nitrofurantoin | NITROFURANTOIN MONOHYDRATE 25 mg/5mL | Suspension · Oral | Rising Pharma Holdings, Inc. | 64980-0593-24 |
| Nitrofurantoin | NITROFURANTOIN 25 mg/5mL | Suspension · Oral | Amneal Pharmaceuticals LLC | 65162-0689-88 |
| Nitrofurantoin | NITROFURANTOIN 25 mg/5mL | Suspension · Oral | Biocon Pharma Inc | 70377-0118-31 |
| Nitrofurantoin | NITROFURANTOIN 25 mg/5mL | Suspension · Oral | ANI Pharmaceuticals, Inc. | 70954-0496-10 |
| Nitrofurantoin | NITROFURANTOIN 25 mg/5mL | Suspension · Oral | NorthStar Rx LLC | 72603-0176-01 |
Alternative dosage forms of Nitrofurantoin
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 11 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Nitrofurantoin 25 mg/5mL | Aurobindo | 1 bottle | $1.686 | AB | Availability likely |
| Nitrofurantoin 25 mg/5mL | Rising | 1 bottle | $1.686 | AB | Availability likely |
| Nitrofurantoin 25 mg/5mL | Amneal | 1 bottle | $1.686 | — | Availability likely |
| Nitrofurantoin 25 mg/5mL | Somerset | 1 bottle | $1.686 | AB | Availability likely |
| Nitrofurantoin 25 mg/5mL | Biocon | 1 bottle | $1.686 | AB | Availability likely |
| Nitrofurantoin 25 mg/5mL | ANI | 230 ml | $1.686 | AB | Availability likely |
| Nitrofurantoin 25 mg/5mL | NorthStar | 1 bottle | $1.686 | AB | Availability likely |
| Nitrofurantoin 25 mg/5mL | Camber | 1 bottle | — | AB | FDA listed |
| Nitrofurantoin 25 mg/5mL | Novel | 1 bottle | — | AB | FDA listed |
| Nitrofurantoin 25 mg/5mL | Lupin | 1 bottle | — | AB | FDA listed |
| Nitrofurantoin 25 mg/5mL | Amneal | 230 ml | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Nitrofurantoin Oral Suspension — that fall in the same broad treatment class (nitrofuran derivatives antibacterial agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other anti-infective, other shortages
Nitrofurantoin Oral Suspension shortage FAQs
Is Nitrofurantoin Oral Suspension in shortage?
Which products are affected?
When will Nitrofurantoin Oral Suspension be available again?
Can I still get Nitrofurantoin somewhere?
What should I do if I take Nitrofurantoin Oral Suspension?
Still have a question about the Nitrofurantoin Oral Suspension shortage?
Ask a pharmacist about this shortage →View Nitrofurantoin Oral Suspension on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.